ATOS
Atossa Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ATOS fundamentals
Atossa Therapeutics (ATOS) released its earnings on Aug 12, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -0.07 (YoY -40.00%), missed estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.07
-40.00%
Report date
Aug 12, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Atossa Therapeutics (ATOS) key financial stats and ratios, covering profitability, financial health, and leverage.
Atossa Therapeutics (ATOS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Atossa Therapeutics (ATOS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Atossa Therapeutics (ATOS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Atossa Therapeutics (ATOS) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Atossa Therapeutics (ATOS) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
Did Atossa Therapeutics beat or miss consensus estimates last quarter?What is Atossa Therapeutics's gross profit margin?What guidance did Atossa Therapeutics's management provide for the next earnings period?What does Atossa Therapeutics do and what are its main business segments?What is Atossa Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Atossa Therapeutics's earnings call?What factors drove the changes in Atossa Therapeutics's revenue and profit?What were the key takeaways from Atossa Therapeutics’s earnings call?
